Tetrathiomolybdate, a copper chelator, inhibits ATP7B activity in ovarian cancer models, restoring cisplatin sensitivity by blocking drug export (Ryumon et al., 2019; Fang et al., 2019). The gene discussed is ATP7B; the disease is ovarian cancer.